NCT03244878

Thrive, a Computerized Cognitive Behavior Therapy Program to Treat Depression

Completed NA Last updated 14 August 2018

What this trial tests

NA trial testing Thrive in Depressive Symptoms in 464 participants. Completed in 31 January 2018.

Timeline

1 May 2017

Primary endpoint
31 January 2018

31 January 2018

Quick facts

Lead sponsor	Montana State University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	464
Start date	1 May 2017
Primary completion	31 January 2018
Estimated completion	31 January 2018
Sites	1 location across United States

Drugs / interventions tested

• Thrive

Conditions studied

• Depressive Symptoms — all drugs for Depressive Symptoms →

Sponsor

Montana State University

Who can join

18 and older, any sex, with Depressive Symptoms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates a culturally-modified version of Thrive, a computerized Cognitive Behavior Therapy program to treat depressive symptoms, syndromes, and disorders among rural Montanans. Study participants will be randomized to either a wait-list treatment as usual or the Thrive program. After 8 weeks, the wait-list group will then receive Thrive. The primary assessment measure is the Patient Health Questionnaire-9.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

1. Use of a Fully Automated Internet-Based Cognitive Behavior Therapy Intervention in a Community Population of Adults With Depression Symptoms: Randomized Controlled Trial.
   Schure MB, Lindow JC, Greist JH, Nakonezny PA, et al · · 2019 · cited 33× · PMID 31738173 · DOI 10.2196/14754
2. Twelve-Month Follow-Up to a Fully Automated Internet-Based Cognitive Behavior Therapy Intervention for Rural Adults With Depression Symptoms: Single-Arm Longitudinal Study.
   Schure M, McCrory B, Tuchscherer Franklin K, Greist J, et al · · 2020 · cited 8× · PMID 33006561 · DOI 10.2196/21336